JONES Chellappan SUMATHI

Dr. JONES Chellappan SUMATHI

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
Vidhya Rekha UmapathyVidhya Rekha Umapathy
Vidhya Rekha Umapathy
PMPrabhu ManickamNatarajan
Prabhu ManickamNatarajan
BSBhuminathan Swamikannu
Bhuminathan Swamikannu
JMJohnson Moses
Johnson Moses
JSJONES Chellappan SUMATHI
JONES Chellappan SUMATHI
MAM.K kannan Anbumozhi
M.K kannan Anbumozhi
Oral cancer is a serious concern to people all over the world because of its high mortality rate and metastatic spread to other areas of the body. Despite recent advancements in biomedical research, OC detection at an early stage remains a challenge and is complex and inaccurate with conventional diagnostics procedures. It is critical to study innovative approaches that can enable a faster, easier, non-invasive, and more precise diagnosis of OC in order to increase the survival rate of patients. In this paper, we conducted a review on how biosensors might be an excellent tool for detecting OC. This review covers the strategies that use different biosensors to target various types of biomarkers and focuses on biosensors that function at the molecular level viz. DNA biosensors, RNA biosensors, and protein biosensors. In addition, we reviewed non-invasive electrochemical methods, optical methods, and nano biosensors to analyze the OC biomarkers present in body fluids such as saliva and serum. As a result, this review sheds light on the development of ground-breaking biosensors for the early detection and diagnosis of OC.

21 February 2024 in Cureus
Verified
Journal Article
Open access
APAnandan P
Anandan P
SRSanthanam Rengarajan
Santhanam Rengarajan
SVSankar Venkatachalam
Sankar Venkatachalam
SPSasikumar Pattabi
Sasikumar Pattabi
JSJONES Chellappan SUMATHI
JONES Chellappan SUMATHI
KPKrishna Prasanth
Krishna Prasanth
Objectives: Citicoline and cerebrolysin are two unique yet contentious medications because of inconsistencies in efficacy as well as the mystery surrounding their mode of action. The current study aimed to re -validate the neuroprotective benefits of these medications and investigate the possible molecular mechanism. Methods: Neuro-2A cells were exposed to tert-butyl hydroperoxide, a consistent in vitro model of neuronal damage caused by oxidative stress. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, acridine orange/ethidium bromide (AO-EtBr) staining, and phase -view examinations were utilized to evaluate cell survival and cytotoxicity. Real-time reverse transcription-polymerase chain reaction (RT-PCR)-based gene expression studies were conducted. Key finding: Observations revealed that these two medications had modest but considerable neuroprotective effects. While the majority of the genes' expressions remained unchanged, cerebrolysin upregulated Neuregulin 1, and both upregulated brain -derived neurotrophic factor (BDNF) expression. Conclusion: The findings of the current study may be the first to suggest that citicoline and cerebrolysin may increase host cells' defense mechanisms (secretion neurotrophic factors) rather than carrying nutrients for cell survival. Because of its simplicity, the current study can readily be repeated to learn more about these two disputed medications for treating ischemic stroke.

1 January 2023 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
PGPriyanka Ganapathy
Priyanka Ganapathy
VSVidya Devanatha Desikan Sheshadri
Vidya Devanatha Desikan Sheshadri
RSRajesh Sarkar
Rajesh Sarkar
JSJONES Chellappan SUMATHI
JONES Chellappan SUMATHI
KGKrishnamoorthy Gunasekaran
Krishnamoorthy Gunasekaran
SBSaleem Basha
Saleem Basha
Background. The regulation of vascular endothelial growth factor (VEGF) by genetic factors in T2DM and DFU still requires thorough investigation. Hence, the present study aimed to investigate the association of VEGF +405 G/C in DFU subjects and correlate it with its circulatory levels, infection severity, and amputation rate. Materials and Methods. This study registered a total of 754 participants of which group I: healthy controls (n = 297), group II: T2DM subjects (n = 242), and group III: DFU subjects (n = 215). Genotyping and levels of rs2010963 were analyzed by polymerase chain reaction‐restriction fragment length polymorphism (PCR‐RFLP) and ELISA, respectively. Results. Results of the current study showed a clear decline in circulatory VEGF‐A levels in DFU subjects. VEGF‐A was decreased in DFU subjects with the mutant “CC” genotype. The mutant “CC” of VEGF +405G/C was also found to be more susceptible to ulcer grade (III and IV) and major amputations. Conclusion. VEGF +405G/C SNP is associated with levels, infection severity, and amputation amongst South Indian DFU patients.

4 January 2025 in Waste and Biomass Valorization
Verified
Journal Article
Closed access
PDF file
SSShaina Sharma
Shaina Sharma
SGSimarpreet Kaur Gill
Simarpreet Kaur Gill
SSSudarshan Sahu
Sudarshan Sahu
GSGursharan Singh
Gursharan Singh
SAShailendra Kumar Arya
Shailendra Kumar Arya
RVRamesh Vediyappan
Ramesh Vediyappan

20 May 2024 in Cureus
Verified
Journal Article
Open access
PDF file
APAnandhan P
Anandhan P
MKMuttevi Hayagreva Kumar
Muttevi Hayagreva Kumar
SESaad H. Elshafey
Saad H. Elshafey
JSJanaki C. S
Janaki C. S
JSJONES Chellappan SUMATHI
JONES Chellappan SUMATHI
PKPrabhu K
Prabhu K
The utilization of herbal formulations for the management of reproductive tract disorders has been a longstanding practice in traditional medicine. In this study, we investigated the efficacy of a herbal extract, Shalmali (Bombax ceiba), in addressing uterine bleeding, a common concern in gynecological health. Through gene expression analysis, this study examined the impact of Shalmali extract on key genes associated with uterine bleeding, namely ESR1, CD56, and SDF-1, in the human endometrial stromal cell line (T HESC). Our findings revealed a dose-dependent decrease in ESR1 and CD56 gene expression levels following treatment with Shalmali extract, suggesting its potential to modulate hormonal and cellular processes involved in uterine bleeding. Notably, an increase in SDF-1 gene expression was observed, indicating a possible role of Shalmali extract in promoting tissue repair and regeneration. Comparison with the standard drug tranexamic acid demonstrated similar effects on gene expression levels, further validating the therapeutic potential of Shalmali extract. Agarose gel electrophoresis images supported these findings, showing reduced gene expression in cells treated with Shalmali extract comparable to those treated with tranexamic acid. These results underscore the promising efficacy of Shalmali extract as a natural alternative for managing uterine bleeding, potentially offering a safe and effective treatment option for individuals seeking traditional remedies for gynecological concerns. Further research is warranted to elucidate the underlying mechanisms of action and assess the long-term safety and efficacy of Shalmali extract in clinical settings.

15 June 2026 in Materials Technology Reports
Verified
Journal Article
Open access
FRFareenpoornima Rafiq
Fareenpoornima Rafiq
JSJONES Chellappan SUMATHI
JONES Chellappan SUMATHI
PGParthipan Govindsamy
Parthipan Govindsamy
PPPapitha Purushothaman
Papitha Purushothaman
The research reports first on the optical properties of BaCoO2.6 nanoparticles, using the transmission spectrum, viz., the band gap. The nanoparticle size of 25 nm with grain size ranging from 0.5 μm to 5 μm was revealed. Tauc's indirect transition model describes the optical band gap (Eg) as 5.28 eV, using which the optical features such as extinction coefficient, refractive index, and the loss function have been evaluated. The synthesized sample's average refractive index lies in the range 1.0–2.5, the Urbach energy, calculated from inter-band localized electronic states generated by defects, was found to be 2.01 eV. As the entire region does not bear any absorption band, the sample finds its suitability in NLO-SHG devices. Interesting outcomes in line with optical properties were also demonstrated by the photoluminescence properties. The electron transition at 800 nm, which is also linked to the electronic transition of Co2+/Co3+ ions, is responsible for the peak. The electrons may be trapped at the oxygen vacancies at a tetrahedral site, or they may be caused by impurities or structural flaws in the material and may suggest a mixed phase transition. The magnetic squareness ratio being less than 0.5 emphasizes the synthesized sample’s anisotropic, single-domain, soft magnetic nature. The present exploration of BaCoO2.6 nanoparticles highlights that their antimicrobial efficacy extends well beyond conventional growth inhibition metrics such as the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC).